Urine and serum midkine levels in an Australian chronic kidney disease clinic population: an observational study

BACKGROUND AND OBJECTIVES: The cytokine midkine (MK) is pathologically implicated in progressive chronic kidney disease (CKD) and its systemic consequences and has potential as both a biomarker and therapeutic target. To date, there are no published data on MK levels in patients with different stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Victoria K, Anstey, Chris M, Gately, Ryan P, Comeau, Drew C, Clark, Carolyn J, Noble, Euan P, Mahadevan, Kumar, Hollett, Peter R, Pollock, Andrea J, Hall, Sharron T, Jones, Darren R, Burg, Dominic, Gray, Nicholas A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623449/
https://www.ncbi.nlm.nih.gov/pubmed/28963279
http://dx.doi.org/10.1136/bmjopen-2016-014615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623449/
https://www.ncbi.nlm.nih.gov/pubmed/28963279
http://dx.doi.org/10.1136/bmjopen-2016-014615

Ejemplares similares